World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
62
Citations
15937
World Ranking
3121
National Ranking
45

Eric Veys publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Eric Veys sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 233 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Eric Veys D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Eric Veys sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 62 D-Index — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Eric Veys is affiliated with Ghent University Hospital in Belgium and specializes in the fields of medicine, with a focus on urology and rheumatology. Their work predominantly addresses topics related to urinary bladder and prostate research, pelvic floor disorders treatments, and urological disorders and treatments.

Their recent research includes the publication titled "Voiding camp: A successful and unique bladder rehabilitation program for children with urinary incontinence", released in 2024 through the Journal of Pediatric Urology. This article reflects an interest in innovative therapeutic approaches within pediatric urology.

Frequent coauthors collaborating with Eric Veys include:

  • Lien Dossche
  • Catherine Renson
  • Anne-Françoise Spinoit
  • Els J. M. Van Damme
  • M. Waterschoot

The primary venue for publishing their work is the Journal of Pediatric Urology, which aligns with their specialization.

Eric Veys' research topics demonstrate a concentration on conditions affecting the urinary bladder and prostate, as well as treatments for pelvic floor disorders. Their contributions relate closely to improving therapies and rehabilitation programs in these areas.

Best Publications

  • Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.

    Filip Van den Bosch;Elli Kruithof;Dominique Baeten;Annemie Herssens

  • Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations

    L De Rycke;I Peene;I E A Hoffman;E Kruithof

  • Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study

    F Van den Bosch;E Kruithof;D Baeten;F De Keyser

  • Transplantation of viable meniscal allograft. Survivorship analysis and clinical outcome of one hundred cases.

    Peter C.M. Verdonk;Alex Demurie;Karl Fredrik Almqvist;Eric M. Veys

  • Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis

    Elli Kruithof;Dominique Lp Baeten;Leen De Rycke;Bernard Vandooren

  • Ankylosing spondylitis and bowel disease

    Dominique Baeten;Filip De Keyser;Herman Mielants;Eric M Veys

  • Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity.

    D Baeten;P Demetter;C Cuvelier;F Van Den Bosch

  • Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy

    Leen De Rycke;Elli Kruithof;Nancy Van Damme;Ilse E. A. Hoffman

  • Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis

    Gfm Verheijden;Awm Rijnders;E Bos;Cjjc deRoo

  • Characterisation of human knee meniscus cell phenotype

    P.C.M. Verdonk;R.G. Forsyth;J. Wang;K.F. Almqvist

  • The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects.

    Mielants H;Veys Em;Cuvelier C;De Vos M

  • Long-term evolution of gut inflammation in patients with spondyloarthropathy

    M De Vos;H Mielants;C Cuvelier;A Elewaut

  • Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study.

    Dominique Baeten;Dominique Baeten;Elli Kruithof;Filip Van den Bosch;Pieter Demetter

  • Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: Relevance to antifilaggrin autoantibodies

    Dominique Baeten;Isabelle Peene;Ann Union;Lydie Meheus

  • Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy.

    Dominique Baeten;Pieter Demetter;Claude A. Cuvelier;Elli Kruithof

  • Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition

    S. Goemaere;C. Ackerman;K. Goethals;F. De Keyser

  • Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?

    D Baeten;E Kruithof;F Van den Bosch;N Van den Bossche

  • Ileocolonoscopic Findings in Seronegative Spondylarthropathies

    H. Mielants;E. M. Veys;C. Cuvelier;M. de Vos

  • Histopathology of intestinal inflammation related to reactive arthritis.

    C Cuvelier;C Barbatis;H Mielants;M De Vos

  • Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis.

    Leen de Rycke;Dominique Baeten;Elli Kruithof;Filip Van den Bosch

  • Human cartilage gp‐39+,CD16+ monocytes in peripheral blood and synovium: Correlation with joint destruction in rheumatoid arthritis

    D. Baeten;A. M. H. Boots;P. G. A. Steenbakkers;D. Elewaut

  • Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial.

    M Dougados;A Gueguen;J P Nakache;P Velicitat

  • Ileocolonoscopy in seronegative spondylarthropathy.

    M. De Vos;C. Cuvelier;H. Mielants;E. Veys

  • HLA-B27 related arthritis and bowel inflammation. Part 2. Ileocolonoscopy and bowel histology in patients with HLA-B27 related arthritis.

    Mielants H;Veys Em;Cuvelier C;De Vos M

  • Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy

    Dominique Lp Baeten;Elli Kruithof;Leen De Rycke;Anemieke M Boots

  • Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis–specific humoral autoimmunity

    Leen De Rycke;Anthony P. Nicholas;Tineke Cantaert;Elli Kruithof

  • Needle arthroscopy of the knee with synovial biopsy sampling: technical experience in 150 patients.

    D Baeten;F Van den Bosch;D Elewaut;A Stuer

  • Transplantation of Viable Meniscal Allograft: Surgical Technique

    Peter C.M. Verdonk;Alex Demurie;Karl Fredrik Almqvist;Eric M. Veys

Frequent Co-Authors

Filip De Keyser
Filip De Keyser Ghent University Hospital
Herman Mielants
Herman Mielants Ghent University Hospital
Dominique Baeten
Dominique Baeten University of Amsterdam
Dirk Elewaut
Dirk Elewaut Ghent University
Paul P. Tak
Paul P. Tak GlaxoSmithKline (United Kingdom)
Johannes Roth
Johannes Roth University of Münster
Dieter Deforce
Dieter Deforce Ghent University
Dirk Foell
Dirk Foell University of Münster
Barry Bresnihan
Barry Bresnihan University College Dublin
Kaisa Granfors
Kaisa Granfors University of Turku

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related nursing pathways can broaden career opportunities in healthcare and research. Many who start in Immunology pursue advanced nursing qualifications to work directly with patients or in clinical settings.

One popular route is through online RN programs for non nurses, which allow individuals from non-nursing backgrounds to transition efficiently into registered nursing roles. These programs often offer flexibility for working professionals.

For those seeking an accelerated path, the 12-month accelerated nursing programs provide an intensive, fast-tracked option to earn a Bachelor of Science in Nursing, merging foundational science knowledge with practical nursing skills.

Entry-level options like LPN schools easy to get into offer accessible routes to begin nursing careers, especially for those seeking quicker workforce entry and foundational clinical experience.

For advanced practice, exploring the easiest online nurse practitioner programs can open doors to specialized roles with greater autonomy in patient care, combining clinical expertise with leadership in healthcare settings.

Best Scientists Citing Eric Veys

Recently Published Articles